Skip to content
Home/Companies/Biotech/HEPHAISTOS-Pharma
HP

HEPHAISTOS-Pharma

Biotech·France·Active·2yr hold

HEPHAISTOS-Pharma is a biotechnology company, headquartered in France.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns HEPHAISTOS-Pharma?

HEPHAISTOS-Pharma is currently owned by Elaia Partners through DTS3 (2024 vintage), since 2024.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
DTS3 · 2024 · VC

Key facts

HQFrance
SectorBiotechnology

More from DTS3

Other portfolio companies in the same fund.

GetVocal AI
Active
Data & AnalyticsFrance· 2025
Mimic Robotics
Active
IndustrialsUS· 2025
Proxima Fusion
Active
EnergyGermany· 2025
Streambased
Active
Data & AnalyticsUK· 2025
Biophta
Active
BiotechFrance· 2024
dottxt
Active
Data & AnalyticsFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings